SMARCA4 and melanoma: This requirement for BRG1 to drive a large gene expression programme required for melanoma cell proliferation in vitro contrasts with its tumour suppressor function in human cancers including melanoma (Hargreaves and Crabtree, 2011; Shain and Pollack, 2013; Bastian, 2014; Wang et al., 2014).